PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Breakthrough UC San Diego brain recording device receives FDA approval for a clinical trial

Breakthrough UC San Diego brain recording device receives FDA approval for a clinical trial
2024-06-19
(Press-News.org) Video: https://youtu.be/-7ggs6e2UXI?si=lnFqEscjJh-91n64

B-roll: https://youtu.be/pvNBa733ICw?si=DotUuQkxVgMQ0jY7

The Federal Drug Administration approved a clinical trial to test the effectiveness of an electronic grid that records brain activity during surgery, developed by engineers at the University of California San Diego.

The device with nanoscale sensors records electrical signals directly from the surface of the human brain in record-breaking detail. The grid’s breakthrough resolution could provide better guidance for planning and performing surgeries to remove brain tumors and treat drug-resistant epilepsy. 

The grid’s higher resolution for recording brain signals could improve neurosurgeons’ ability to minimize damage to healthy brain tissue. During epilepsy surgery, the novel grid could improve the ability to precisely identify the regions of the brain where epileptic seizures originate for safe and effective treatment.

The new brain sensor array, known as platinum nanorod grid (PtNRGrid) features a densely packed grid of a record-breaking 1,024 embedded electrocorticography (ECoG) sensors. The device rests on the surface of the brain and is approximately 6 microns thin–smaller than one tenth of the human hair–and flexible. As a result, it can both adhere and conform to the surface of the brain, bending as the brain moves while providing high-quality, high-resolution recordings of brain activity. In contrast, the ECoG grids most commonly used in surgeries today typically have between 16 and 64 sensors. These grids are rigid, stiffer and more than 0.5 mm in thickness and do not conform to the curved surface of the brain.

The PtNRGrid was invented by Shadi Dayeh, a Professor in the Department of Electrical and Computer Engineering at the University of California San Diego and members of his team. Over the years, the team developed the PtNRGrid technology in collaboration with neurosurgeons and medical researchers from UC San Diego, Massachusetts General Hospital (MGH) and Oregon Health & Science University (OHSU).

“This accomplishment ushers in a new era of clinical neuroscience and neuromonitoring,” Dayeh said. “We are very excited to receive the FDA approval to apply our groundbreaking PtNRGrid in a clinical setting. It is a credit  to the hard work of my team members who worked tirelessly to meet the quality criteria mandated by the FDA. I am also grateful to my clinical partners, the support of the NIH, and to the campus leadership that fostered an impactful ecosystem across engineering and medicine to transform the future of healthcare.”

The FDA approved an investigational device exemption (IDE) for a “pivotal study [titled] “Systematic Evaluation of Platinum Nanorod Grids (PtNRGrids) for Intraoperative Mapping and Neurophysiological Monitoring (IONM) During Brain Surgeries.” 

Specifically, the clinical trial is designed to demonstrate the effectiveness of the PtNRGrid device to map both normal and pathological brain activity. During the trial, UC San Diego engineers will partner with clinician-scientists: Drs. Sharona Ben-Haim and Eric Halgren at UC San Diego, Dr. Sydney Cash at MGH, and Dr. Ahmed Raslan at OHSU. In a first phase,  surgeons will implant the PtNRGrid in 20 patients, then measure and compare  the grid’s performance with the present state-of-the-art. The PtNRGrid will be deployed in surgeries to remove brain tumors and to remove tissue that causes epileptic seizures. 

Record-breaking density Dayeh’s team has pioneered human brain and spinal cord mapping with thousands of channels since 2019, and has reported early safety and efficacy results in a series of articles published in Science Translational Medicine in 2022 in human subjects. PtNRGrid is the only device with thousands of channels to demonstrate in peer-reviewed publications that it can map motor and language brain activity, as well as epileptic discharges, by producing panoramic videos of brain waves over 10 square centimeters of the brain’s cortex while maintaining resolution at a microscopic level. 

 Currently, Dayeh’s research group holds the world record of recording brain activity from a single cortical grid with 2,048 channels on the surface of the human brain published in Science Translational Medicine in 2022. The device was used in the operating room of Dr. Ahmed Raslan of the OHSU. Since then, the team has increased the number of recording channels to 4,096 and continues to work on increasing the number of channels in the grid to monitor brain activity in even higher resolution.

Pending success of this staged trial, the team will transition to the next crucial step of making the PtNRGrid available for commercial use at scale. Demonstrating that ECoG grids with sensors in the thousands of channels record brain activity with high fidelity also opens new opportunities in neuroscience for uncovering a deeper understanding of how the human brain functions. Basic science advances, in turn, could lead to improved treatments grounded in enhanced understanding of brain function.

“Our goal is to provide a new atlas for understanding and treating neurological disorders, working with a network of highly experienced clinical collaborators at UC San Diego, MGH, and OHSU,” Dayeh said. 

Dayeh’s work toward the FDA approval is supported by an NIH BRAIN® Initiative award # UG3NS123723.

 

 

 

 

END

[Attachments] See images for this press release:
Breakthrough UC San Diego brain recording device receives FDA approval for a clinical trial Breakthrough UC San Diego brain recording device receives FDA approval for a clinical trial 2 Breakthrough UC San Diego brain recording device receives FDA approval for a clinical trial 3

ELSE PRESS RELEASES FROM THIS DATE:

A study led by ISGlobal and IDIAPJGol recommends strengthening immunity against COVID-19 in people with cancer

2024-06-19
Researchers from the Institut d’Investigació en Atenció Primària Jordi Gol (IDIAPJGol) and the Barcelona Institute for Global Health (ISGlobal), a center promoted by “la Caixa” Foundation, have led a study on the effectiveness of vaccines against COVID-19 among cancer patients in Catalonia. The research, published in the journal Nature Communications, recommends administering additional doses of the vaccine among this risk population. Cancer patients are at increased risk of death from COVID-19, especially ...

A railroad of cells

A railroad of cells
2024-06-19
Looking under the microscope, a group of cells slowly moves forward in a line, like a train on the tracks. The cells navigate through complex environments. A new approach by researchers involving the Institute of Science and Technology Austria (ISTA) now shows how they do this and how they interact with each other. The experimental observations and the following mathematical concept are published in Nature Physics. The majority of the cells in the human body cannot move. Some specific ones, however, can go to different places. For example, in wound healing, cells move through the body to repair damaged tissue. They sometimes ...

Much of the Nord Stream gas remained in the sea

Much of the Nord Stream gas remained in the sea
2024-06-19
Much of the methane released into the southern Baltic Sea from the Nord Stream gas pipeline has remained in the water. This is shown by measurements taken by researchers from the University of Gothenburg. At the end of September 2022, the Nord Stream gas pipeline on the bottom of the Baltic Sea exploded east of Bornholm and one of the largest unnatural methane gas emissions ever was a fact. The methane gas from the pipeline created large bubbles at the water surface and measurements showed elevated levels of methane in the atmosphere. Expedition ...

Dwindling arousal levels during brain scans have been distorting fMRI results, study shows

2024-06-19
In a new study, investigators from McLean Hospital (a member of Mass General Brigham), Harvard Medical School and the National Institute on Drug Abuse – Intramural Research Program (NIDA-IRP) discovered that the tendency of people’s arousal to wane over the course of brain scans has been distorting the brain connection maps produced by functional magnetic resonance imaging (fMRI). The team found that as people’s arousal levels dwindle during an fMRI, such as if they become more relaxed and sleepy, changes in breathing and heart rates alter blood oxygen levels in the ...

New Czech company linked to IOCB Prague to enter global gene therapy field

New Czech company linked to IOCB Prague to enter global gene therapy field
2024-06-19
Technology from the laboratories of IOCB Prague has been given an extraordinary opportunity to succeed in the rapidly developing segment of gene therapy. The results of successful research are set to be advanced by a newly established private company called Adalid Sciences, which is being supported with a major investment from BTL Group, a leading manufacturer of medical technologies.  The story begins with the discovery of new lipid nanoparticles with a comic book name coined by Dr. Petr Cígler and Dr. Klára Grantz Šašková of IOCB Prague. Acting as a sort of imaginary courier, their XMAN is capable of safely ...

New findings: East Palestine train derailment caused chemical pollution falling to the earth surface across the US and beyond 

New findings: East Palestine train derailment caused chemical pollution falling to the earth surface across the US and beyond 
2024-06-19
A new study published in the academic journal Environmental Research Letters, reveals that the environmental impact of the February 3, 2023, Norfolk Southern train accident in East Palestine, Ohio covered a very large geographical area. Inorganic pollutants released due to the accident were found in wet weather downfall (wet deposition) from the Midwest through the Northeast reaching as far as southern Canada and North Carolina. The findings are significant as many inorganic pollutants in rain and snow have chemical effects on - aquatic flora and fauna. According to the paper, these pollutants spread over at least portions of 16 states and an area of 1.4 million ...

Interaction with insects accelerates plant evolution

Interaction with insects accelerates plant evolution
2024-06-19
A team of researchers at the University of Zurich has discovered that plants benefit from a greater variety of interactions with pollinators and herbivores. Plants that are pollinated by insects and have to defend themselves against herbivores have evolved to be better adapted to different types of soil. Plants obtain nutrients and water from the soil. Since different soil types differ in their chemical and physical composition, plants need to adapt their physiology to optimize this process on different soil types. This evolutionary ...

More effective cancer treatment with iontronic pump

More effective cancer treatment with iontronic pump
2024-06-19
When low doses of cancer drugs are administered continuously near malignant brain tumours using so-called iontronic technology, cancer cell growth drastically decreases. Researchers at Linköping University, Sweden, and the Medical University of Graz, Austria, demonstrated this in experiments with bird embryos. The results, published in the Journal of Controlled Release, is one step closer to new types of effective treatments for severe cancer forms. Malignant brain tumours often recur despite surgery and post-treatment with chemotherapy and radiation. This is because cancer cells can “hide” deep within tissue and then regrow. ...

Ultrasound beam triggers ‘nanodroplets' to deliver drugs at exactly the right spot

2024-06-19
Conventional drug delivery is often like cracking a nut with a sledgehammer. Whether the drug is swallowed, injected, inhaled, or absorbed through the skin, it ultimately diffuses to most parts of the body, including those where it isn’t needed – or where it even might cause harm. But what if the delivery could be targeted at exactly the right spot? This would allow the total dose to be dramatically lower, thus minimizing side-effects. Now, scientists from the US have found a way to perfect a promising, ...

Blessing in disguise: Mycoviruses enhance fungicide effectiveness against plant pathogens

Blessing in disguise: Mycoviruses enhance fungicide effectiveness against plant pathogens
2024-06-19
Osaka, Japan — As detrimental as viruses may sound, they can be helping hands for farmers when it comes to dealing with plant pathogens. Osaka Metropolitan University scientists have discovered that a mycovirus that infects plant pathogenic oomycete Globisporangium ultimum can increase the latter’s sensitivity to specific fungicides. Their findings could lead to innovative approaches for controlling plant diseases, reducing reliance on chemical treatments, and minimizing agricultural loss. Their results were published in Microbiological Research ...

LAST 30 PRESS RELEASES:

Osteoporosis treatment benefits people older than 80

Consuming more protein may protect patients taking anti-obesity drug from muscle loss

Thyroid treatment may improve gut health in people with hypothyroidism

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

High blood sugar may have a negative impact on men’s sexual health

Emotional health of parents tied to well-being of children with growth hormone deficiency

Oxytocin may reduce mood changes in women with disrupted sleep

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce

Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes

New research expands laser technology

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers

Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes

CTE and normal aging are difficult to distinguish, new study finds

Molecular arms race: How the genome defends itself against internal enemies

Tiny chip speeds up antibody mapping for faster vaccine design

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

[Press-News.org] Breakthrough UC San Diego brain recording device receives FDA approval for a clinical trial